Stockscreener 앱 받기
35.93
8.44%
-3.31
시간 외 거래:
35.93
전일 마감가:
$39.24
열려 있는:
$42.07
하루 거래량:
2.07M
Relative Volume:
1.81
시가총액:
$2.38B
수익:
$277.49M
순이익/손실:
$-192.14M
주가수익비율:
-10.69
EPS:
-3.36
순현금흐름:
$-95.52M
1주 성능:
-9.95%
1개월 성능:
-0.72%
6개월 성능:
-16.71%
1년 성능:
-12.81%
1일 변동 폭
$35.25
$42.07
1주일 범위
$35.25
$42.07
52주 변동 폭
$33.16
$60.90
트위스트 바이오사이언스 Stock (TWST) Company Profile
명칭
Twist Bioscience Corp
전화
800-719-0671
주소
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
TWST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
35.93 | 2.38B | 277.49M | -192.14M | -95.52M | -3.36 |
|
TMO
Thermo Fisher Scientific Inc
|
422.27 | 159.05B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
197.40 | 140.21B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
475.07 | 34.90B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
108.37 | 30.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
152.30 | 26.47B | 15.41B | 1.37B | 2.11B | 7.50 |
트위스트 바이오사이언스 Stock (TWST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-13 | 개시 | Wolfe Research | Outperform |
| 2024-06-04 | 개시 | Guggenheim | Buy |
| 2024-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-27 | 개시 | Berenberg | Buy |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2023-01-03 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-03-02 | 재개 | Cowen | Outperform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-29 | 개시 | William Blair | Outperform |
| 2021-06-04 | 개시 | Goldman | Neutral |
| 2021-04-12 | 개시 | Piper Sandler | Overweight |
| 2021-02-05 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-10-20 | 개시 | SVB Leerink | Mkt Perform |
| 2019-05-31 | 개시 | Evercore ISI | Outperform |
| 2018-11-26 | 개시 | JP Morgan | Neutral |
모두보기
트위스트 바이오사이언스 주식(TWST)의 최신 뉴스
Leerink maintains $40 target on Twist Bioscience stock - Investing.com
Twist Bioscience stock holds $58 target, safe from headwinds By Investing.com - Investing.com India
Barclays maintains $45 target on Twist Bioscience stock - Investing.com
Twist Bioscience stock target trimmed to $50 by Evercore ISI - Investing.com
Twist Bioscience (TWST) Unveils DNA Storage Spin-Off and Reports Strong Q2 Growth - GuruFocus
Earnings call transcript: Twist Bioscience Q2 2025 revenue rises, stock reacts positively - Investing.com Nigeria
TWIST BIOSCIENCE Earnings Results: $TWST Reports Quarterly Earnings - Nasdaq
Twist Bioscience Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Twist Bioscience: Fiscal Q2 Earnings Snapshot - CTPost
Twist Bioscience earnings missed by $0.05, revenue topped estimates - Investing.com
Twist Bioscience Q2 2025 slides: revenue grows 23%, margins approach 50% target - Investing.com
Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results - marketscreener.com
Twist Bioscience (TWST) Spins Off Atlas Data Storage - GuruFocus
Twist Bioscience Spins Out DNA Data Storage As Independent Company - marketscreener.com
Twist Bioscience (TWST) Q2 Earnings: Revenue Surges but EPS Falls Short - GuruFocus
Twist Bioscience Launches Atlas Data Storage as Independent Company With $155M Backing - marketscreener.com
Twist Bioscience (TWST) Reports Q2 Revenue and New Business Launch | TWST Stock News - GuruFocus
Twist Bioscience (TWST) Spins Off DNA Storage Unit as Atlas Data Storage | TWST Stock News - GuruFocus
Twist Bioscience Spins Out DNA Data Storage as Independent Company - Business Wire
Twist Bioscience (TWST) Projected to Post Earnings on Monday - Defense World
What's Next: Twist Bioscience's Earnings Preview - Nasdaq
What To Expect From Twist Bioscience Corp (TWST) Q2 2025 Earnings - GuruFocus
Deeper Dive: Understanding Twist Bioscience Corp (TWST) Through its Various Ratios - DWinneX
How did Twist Bioscience Corp (TWST) fare last session? - uspostnews.com
Analyzing Twist Bioscience Corp (TWST) After Recent Trading Activity - knoxdaily.com
Envestnet Asset Management Inc. Acquires 19,340 Shares of Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience Co. (NASDAQ:TWST) Shares Purchased by Wells Fargo & Company MN - Defense World
Is Twist Bioscience Corp (TWST) a good investment opportunity? - uspostnews.com
Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System - 01net
Cerity Partners LLC Trims Stock Position in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience Co. (NASDAQ:TWST) Shares Acquired by Russell Investments Group Ltd. - Defense World
Legal & General Group Plc Lowers Holdings in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Is Twist Bioscience Corp (NASDAQ: TWST) A Good Pick For New Investors Now? - Stocksregister
Twist Bioscience Co. (NASDAQ:TWST) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Twist Bioscience Co. (NASDAQ:TWST) Shares Purchased by Alliancebernstein L.P. - Defense World
TWST LAWSUIT ALERT: Levi & Korsinsky Notifies Twist Bioscience Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - marketscreener.com
LPL Financial LLC Has $2.32 Million Stock Position in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025 - Business Wire
Barclays Issues Pessimistic Forecast for Twist Bioscience (NASDAQ:TWST) Stock Price - Defense World
Twist Bioscience CFO Sells Shares to Cover Tax Obligations - TradingView
Antibody Discovery Market Size to Achieve USD 22,570 Mn by 2034 | Statifacts - GlobeNewswire Inc.
Twist Bioscience (NASDAQ:TWST) Trading Down 12.1% After Analyst Downgrade - Defense World
Twist Bioscience Corp (TWST) Trading 3.41% Higher on Apr 9 - GuruFocus
Twist Bioscience president sells $7,978 in stock - Investing.com Australia
Twist Bioscience’s chief legal officer sells shares for $4,802 - Investing.com Australia
Twist Bioscience’s chief legal officer sells shares for $4,802 By Investing.com - Investing.com Canada
Twist Bioscience president sells $7,978 in stock By Investing.com - Investing.com Canada
Twist Bioscience CEO Sells Shares to Cover Tax Obligations - TradingView
KLP Kapitalforvaltning AS Takes Position in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
트위스트 바이오사이언스 (TWST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.34%
0.46%
자본화:
|
볼륨(24시간):